IPXL Shareholder Alert: Do You Own Stock in IMPAX Laboratories Inc.?

SAN FRANCISCO, Nov. 3, 2014 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is actively investigating alleged misconduct by Impax Laboratories Inc.'s IPXL top executives, including claims that Impax's officers and directors breached their fiduciary duties to the company.

The Schubert firm's investigation concerns whether Impax's officers and directors breached their fiduciary duties in connection with (a) Impax's responses to various Food and Drug Administration ("FDA") notices and warnings regarding problems in the manufacturing and quality control processes at Impax's production facilities; (b) the oversight of Impax's business; and (c) Impax's disclosures to its shareholders concerning the state of affairs at Impax.

Impax shareholders may have the option to pursue a shareholder derivative action through which shareholders may hold insider wrongdoers accountable for their actions, prevent future misconduct, and bring long-term value back to the company.

If you currently own Impax stock and wish to obtain additional information about the investigation and your legal rights, please contact Dustin Schubert either via email at dschubert@schubertlawfirm.com or by telephone at (415) 788-4220, or fill out the form on our website at http://classactionlawyers.com/impax

About Schubert Jonckheer & Kolbe
Schubert Jonckheer & Kolbe has extensive experience in prosecuting securities claims, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact
Schubert Jonckheer & Kolbe LLP
Dustin L. Schubert, Esq.
3 Embarcadero Center, Suite 1650
San Francisco, CA 94111
Tel: (415) 788-4220

http://www.classactionlawyers.com

SOURCE Schubert Jonckheer & Kolbe LLP